Aviso: para depositar documentos, por favor, inicia sesión e identifícate con tu cuenta de correo institucional de la UCM con el botón MI CUENTA UCM. No emplees la opción AUTENTICACIÓN CON CONTRASEÑA
 

Pharmacology of cardiac potassium channels

dc.contributor.authorTamargo Menéndez, Juan
dc.contributor.authorCaballero Collado, Ricardo
dc.contributor.authorGómez García, Ricardo
dc.contributor.authorValenzuela, Carmen
dc.contributor.authorDelpón Mosquera, María Eva
dc.date.accessioned2023-12-12T13:48:34Z
dc.date.available2023-12-12T13:48:34Z
dc.date.issued2004
dc.description.abstractCardiac K+ channels are membrane-spanning proteins that allow the passive movement of K+ ions across the cell membrane along its electrochemical gradient. They regulate the resting membrane potential, the frequency of pacemaker cells and the shape and duration of the cardiac action potential. Additionally, they have been recognized as potential targets for the actions of neurotransmitters and hormones and class III antiarrhythmic drugs that prolong the action potential duration (APD) and refractoriness and have been found effective to prevent/suppress cardiac arrhythmias. In the human heart, K+ channels include voltage-gated channels, such as the rapidly activating and inactivating transient outward current (Ito1), the ultrarapid (IKur), rapid (IKr) and slow (IKs) components of the delayed rectifier current and the inward rectifier current (IK1), the ligand-gated channels, including the adenosine triphosphate-sensitive (IKATP) and the acetylcholine-activated (IKAch) currents and the leak channels. Changes in the expression of K+ channels explain the regional variations in the morphology and duration of the cardiac action potential among different cardiac regions and are influenced by heart rate, intracellular signalling pathways, drugs and cardiovascular disorders. A progressive number of cardiac and noncardiac drugs block cardiac K+ channels and can cause a marked prolongation of the action potential duration (i.e. an acquired long QT syndrome, LQTS) and a distinct polymorphic ventricular tachycardia termed torsades de pointes. In addition, mutations in the genes encoding IKr (KCNH2/KCNE2) and IKs (KCNQ1/KCNE1) channels have been identified in some types of the congenital long QT syndrome. This review concentrates on the function, molecular determinants, regulation and, particularly, on the mechanism of action of drugs modulating the K+ channels present in the sarcolemma of human cardiac myocytes that contribute to the different phases of the cardiac action potential under physiological and pathological conditions.
dc.description.departmentDepto. de Farmacología y Toxicología
dc.description.facultyFac. de Medicina
dc.description.refereedTRUE
dc.description.statuspub
dc.identifier.citationTamargo J, Caballero R, Gómez R, Valenzuela C, Delpón E. Pharmacology of cardiac potassium channels. Cardiovasc Res. 2004 Apr 1;62(1):9-33. doi: 10.1016/j.cardiores.2003.12.026. PMID: 15023549
dc.identifier.doi10.1016/j.cardiores.2003.12.026
dc.identifier.issn0008-6363
dc.identifier.relatedurlhttps://doi.org/10.1016/j.cardiores.2003.12.026
dc.identifier.urihttps://hdl.handle.net/20.500.14352/91200
dc.issue.number1
dc.journal.titleCardiovascular Research
dc.language.isoeng
dc.page.final33
dc.page.initial9
dc.publisherOxford University Press
dc.rights.accessRightsrestricted access
dc.subject.cdu615.01/.03
dc.subject.keywordK+ channels
dc.subject.keywordCardiomyocytes
dc.subject.keywordPharmacology
dc.subject.keywordCardiac arrhythmias
dc.subject.keywordAntiarrhythmic agents
dc.subject.keywordTorsades de pointes
dc.subject.ucmCiencias Biomédicas
dc.subject.unesco32 Ciencias Médicas
dc.subject.unesco3209 Farmacología
dc.titlePharmacology of cardiac potassium channels
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number62
dspace.entity.typePublication
relation.isAuthorOfPublication22eeb834-bbe3-48f1-a140-d26c5bd0cdd6
relation.isAuthorOfPublication40b81dbc-a87f-4b7d-982a-db1ecdcdf07b
relation.isAuthorOfPublicationdf79fd2c-2e90-44d0-b3ac-76ff241e2fc5
relation.isAuthorOfPublication36742207-526a-45e6-b33e-e711e180a5f9
relation.isAuthorOfPublication.latestForDiscovery22eeb834-bbe3-48f1-a140-d26c5bd0cdd6

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Pharmacology_cardiac_potassium_channels.pdf
Size:
851.55 KB
Format:
Adobe Portable Document Format

Collections